144 related articles for article (PubMed ID: 18481312)
1. Controlled release scaffolds for bone tissue engineering.
Cartmell S
J Pharm Sci; 2009 Feb; 98(2):430-41. PubMed ID: 18481312
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic-designed electrospun bone scaffolds: mesoporous bioactive nanocarriers in hollow fiber composites to sequentially deliver dual growth factors.
Kang MS; Kim JH; Singh RK; Jang JH; Kim HW
Acta Biomater; 2015 Apr; 16():103-16. PubMed ID: 25617805
[TBL] [Abstract][Full Text] [Related]
3. Temporally controlled multiple-gene delivery in scaffolds: A promising strategy to enhance bone regeneration.
Liu J; Xu L; Li Y; Ma J
Med Hypotheses; 2011 Feb; 76(2):173-5. PubMed ID: 20926199
[TBL] [Abstract][Full Text] [Related]
4. Direct fabrication as a patient-targeted therapeutic in a clinical environment.
Hutmacher DW; Woodruff MA; Shakesheff K; Guldberg RE
Methods Mol Biol; 2012; 868():327-40. PubMed ID: 22692620
[TBL] [Abstract][Full Text] [Related]
5. Development of bioactive glass based scaffolds for controlled antibiotic release in bone tissue engineering via biodegradable polymer layered coating.
Nooeaid P; Li W; Roether JA; Mouriño V; Goudouri OM; Schubert DW; Boccaccini AR
Biointerphases; 2014 Dec; 9(4):041001. PubMed ID: 25553876
[TBL] [Abstract][Full Text] [Related]
6. Prospects of chitosan-based scaffolds for growth factor release in tissue engineering.
Sivashankari PR; Prabaharan M
Int J Biol Macromol; 2016 Dec; 93(Pt B):1382-1389. PubMed ID: 26899174
[TBL] [Abstract][Full Text] [Related]
7. Design, fabrication and in vitro evaluation of a novel polymer-hydrogel hybrid scaffold for bone tissue engineering.
Igwe JC; Mikael PE; Nukavarapu SP
J Tissue Eng Regen Med; 2014 Feb; 8(2):131-42. PubMed ID: 22689304
[TBL] [Abstract][Full Text] [Related]
8. Importance of controlled delivery systems for regenerative therapeutics.
Khang G; Tripathy N
Ther Deliv; 2014 Oct; 5(10):1053-5. PubMed ID: 25418264
[No Abstract] [Full Text] [Related]
9. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering.
Habraken WJ; Wolke JG; Jansen JA
Adv Drug Deliv Rev; 2007 May; 59(4-5):234-48. PubMed ID: 17478007
[TBL] [Abstract][Full Text] [Related]
10. Hybrid use of combined and sequential delivery of growth factors and ultrasound stimulation in porous multilayer composite scaffolds to promote both vascularization and bone formation in bone tissue engineering.
Yan H; Liu X; Zhu M; Luo G; Sun T; Peng Q; Zeng Y; Chen T; Wang Y; Liu K; Feng B; Weng J; Wang J
J Biomed Mater Res A; 2016 Jan; 104(1):195-208. PubMed ID: 26282063
[TBL] [Abstract][Full Text] [Related]
11. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
[TBL] [Abstract][Full Text] [Related]
12. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
Lee SH; Shin H
Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
[TBL] [Abstract][Full Text] [Related]
13. Dual-controlled release system of drugs for bone regeneration.
Kim YH; Tabata Y
Adv Drug Deliv Rev; 2015 Nov; 94():28-40. PubMed ID: 26079284
[TBL] [Abstract][Full Text] [Related]
14. Matrices and scaffolds for protein delivery in tissue engineering.
Tessmar JK; Göpferich AM
Adv Drug Deliv Rev; 2007 May; 59(4-5):274-91. PubMed ID: 17544542
[TBL] [Abstract][Full Text] [Related]
15. Osteoinductive fibrous scaffolds of biopolymer/mesoporous bioactive glass nanocarriers with excellent bioactivity and long-term delivery of osteogenic drug.
El-Fiqi A; Kim JH; Kim HW
ACS Appl Mater Interfaces; 2015 Jan; 7(2):1140-52. PubMed ID: 25531645
[TBL] [Abstract][Full Text] [Related]
16. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
[TBL] [Abstract][Full Text] [Related]
17. Macroporous scaffolds associated with cells to construct a hybrid biomaterial for bone tissue engineering.
Rosa AL; de Oliveira PT; Beloti MM
Expert Rev Med Devices; 2008 Nov; 5(6):719-28. PubMed ID: 19025348
[TBL] [Abstract][Full Text] [Related]
18. Enhanced bone tissue formation by alginate gel-assisted cell seeding in porous ceramic scaffolds and sustained release of growth factor.
Florczyk SJ; Leung M; Jana S; Li Z; Bhattarai N; Huang JI; Hopper RA; Zhang M
J Biomed Mater Res A; 2012 Dec; 100(12):3408-15. PubMed ID: 22767533
[TBL] [Abstract][Full Text] [Related]
19. Sustained release of platelet-derived growth factor and vascular endothelial growth factor from silk/calcium phosphate/PLGA based nanocomposite scaffold.
Farokhi M; Mottaghitalab F; Ai J; Shokrgozar MA
Int J Pharm; 2013 Sep; 454(1):216-25. PubMed ID: 23856159
[TBL] [Abstract][Full Text] [Related]
20. Bioactive cell-derived matrices combined with polymer mesh scaffold for osteogenesis and bone healing.
Kim IG; Hwang MP; Du P; Ko J; Ha CW; Do SH; Park K
Biomaterials; 2015 May; 50():75-86. PubMed ID: 25736498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
